Phase 2 Trial Assessing Toxicity of Personalized Response-Based Radiation Treatment in Patients With Locally Advanced Non-Small Cell Lung Cancer.
Edwards DM, Schonewolf CA, Rice JD, Schipper M, Haken RKT, Matuszak M, Balter J, Jarema D, Arenberg DA, Piert M, Qin A, Kalemkerian GP, Schneider BJ, Ramnath N, Chapman CH, Elliott DA, Lawrence TS, Hearn J, Hayman JA, Jolly S.
Edwards DM, et al. Among authors: hayman ja.
Int J Radiat Oncol Biol Phys. 2024 Dec 1;120(5):1332-1343. doi: 10.1016/j.ijrobp.2024.06.018. Epub 2024 Jul 4.
Int J Radiat Oncol Biol Phys. 2024.
PMID: 38971385
Clinical Trial.